苏文电能今年以来股价涨9.96%，近5个交易日跌3.69%，近20日涨8.40%，近60日涨13.09%。 资料显示，苏文电能科技股份有限公司位于江苏武进经济开发区长帆路3号，成立日期2007年4月3日， 上市日期2021年4月27日，公司主营业务涉及为包括房地产、公共事业、工业用户的新建项目、改造项 目、竣工项目提供包含电力新能源设计、电力新能源集成、中低压电力设备供应服务,电力运维,提供包 含分布式光伏、储能、充电桩在内的新能源投资建设。主营业务收入构成为：电力工程建设66.95%， 电力设备供应32.86%，其他(补充)0.19%。 1月16日，苏文电能盘中下跌2.03%，截至10:45，报22.20元/股，成交2.08亿元，换手率4.68%，总市值 45.95亿元。 分红方面，苏文电能A股上市后累计派现4.08亿元。近三年，累计派现2.53亿元。 资金流向方面，主力资金净流出1162.86万元，特大单买入564.56万元，占比2.71%，卖出1321.71万元， 占比6.35%；大单买入4384.74万元，占比21.07%，卖出4790.46万元，占比23.02%。 机构持仓方面，截止2025年9月3 ...

1月16日，滨江集团盘中下跌2.04%，截至10:24，报10.06元/股，成交1.48亿元，换手率0.54%，总市值 313.01亿元。 截至1月9日，滨江集团股东户数3.00万，较上期减少1.60%；人均流通股89521股，较上期增加1.63%。 2025年1月-9月，滨江集团实现营业收入655.14亿元，同比增长60.64%；归母净利润23.95亿元，同比增 长46.60%。 分红方面，滨江集团A股上市后累计派现47.35亿元。近三年，累计派现13.13亿元。 机构持仓方面，截止2025年9月30日，滨江集团十大流通股东中，富国天惠成长混合(LOF)A/B （161005）位居第三大流通股东，持股5000.00万股，相比上期减少300.00万股。香港中央结算有限公司 位居第四大流通股东，持股4687.82万股，相比上期减少446.59万股。信澳星奕混合A（011188）退出十 大流通股东之列。 责任编辑：小浪快报 资金流向方面，主力资金净流出1918.37万元，特大单买入371.52万元，占比2.51%，卖出1350.84万元， 占比9.14%；大单买入2986.18万元，占比20.20%，卖出3925 ...

Group 1 - The core viewpoint of the news is that Lier Chemical has shown significant stock performance and financial growth, with a notable increase in revenue and net profit year-on-year [2][3]. - As of January 16, Lier Chemical's stock price decreased by 2.03% to 14.95 CNY per share, with a total market capitalization of 11.967 billion CNY [1]. - The company has experienced a stock price increase of 14.56% year-to-date, with a 7.40% rise over the last five trading days and a 23.76% increase over the last 60 days [1]. Group 2 - For the period from January to September 2025, Lier Chemical achieved an operating revenue of 6.709 billion CNY, representing a year-on-year growth of 29.31%, and a net profit attributable to shareholders of 381 million CNY, which is a 189.07% increase compared to the previous year [2]. - The company has distributed a total of 1.496 billion CNY in dividends since its A-share listing, with 720 million CNY distributed over the last three years [3]. - As of September 30, 2025, Lier Chemical had 40,300 shareholders, a decrease of 4.20% from the previous period, while the average number of circulating shares per person increased by 4.39% to 19,842 shares [2].

资料显示，融捷股份有限公司位于广东省广州市天河区珠江西路5号广州国际金融中心45层04-05单元， 成立日期1998年8月21日，上市日期2007年12月5日，公司主营业务涉及以新能源锂电材料产业链为主 体,主要包括锂矿采选、锂盐加工及冶炼、锂电设备制造等业务,并参股镍钴锂湿法冶炼及深加工、锂电 池正极材料等业务板块。主营业务收入构成为：锂精矿86.31%，锂电池设备12.76%，锂盐0.66%，其他 0.28%。 融捷股份所属申万行业为：有色金属-能源金属-锂。所属概念板块包括：MSCI中国、锂电池、小金 属、稀缺资源、融资融券等。 1月16日，融捷股份盘中下跌2.01%，截至10:09，报55.45元/股，成交2.96亿元，换手率2.02%，总市值 143.98亿元。 资金流向方面，主力资金净流出4340.46万元，特大单买入1810.83万元，占比6.12%，卖出4429.80万 元，占比14.98%；大单买入5309.74万元，占比17.95%，卖出7031.22万元，占比23.77%。 融捷股份今年以来股价涨7.15%，近5个交易日跌0.93%，近20日涨9.15%，近60日涨41.89%。 分红方 ...

Core Viewpoint - The stock of UCloud has experienced fluctuations, with a recent decline of 2.02% and a total market capitalization of 13.041 billion yuan, reflecting mixed investor sentiment and market activity [1]. Group 1: Stock Performance - As of January 16, UCloud's stock price was 28.58 yuan per share, with a trading volume of 283 million yuan and a turnover rate of 2.40% [1]. - Year-to-date, UCloud's stock has increased by 1.74%, but it has decreased by 5.05% over the last five trading days [1]. - Over the past 20 days, the stock has risen by 17.37%, and over the past 60 days, it has increased by 18.89% [1]. Group 2: Financial Performance - For the period from January to September 2025, UCloud reported a revenue of 1.227 billion yuan, representing a year-on-year growth of 12.17% [2]. - The company recorded a net profit attributable to shareholders of -83.4252 million yuan, which is a significant increase of 49.53% compared to the previous year [2]. Group 3: Shareholder Information - As of December 31, UCloud had 39,300 shareholders, an increase of 8.67% from the previous period [2]. - The average number of circulating shares per shareholder decreased by 7.98% to 10,312 shares [2]. - The top ten circulating shareholders include notable funds, with the 博时上证科创板人工智能ETF increasing its holdings by 601,400 shares [3].

一、证券市场回顾 南财金融终端数据显示，昨日（1月15日，下同）上证综指日内下跌0.33%，收于4112.6点，最高4133.07点；深证成指日内上涨0.41%，收于14306.73点，最 高14328.6点；创业板指日内上涨0.56%，收于3367.92点，最高3372.47点。 二、融资融券情况 | 证券代码 | 证券简称 | 龙虎榜净买入额(万元) | | --- | --- | --- | | 002130.SZ | 沃尔核材 | 82941.07 | | 002446.SZ | 盛路通信 | 32664.5 | | 603011.SH | 合锻智能 | 30784.79 | | 000681.SZ | 视觉中国 | 19509.34 | | 300758.SZ | 七彩化学 | 16204.6 | | 301629.SZ | 矽电股份 | 12905.05 | | 002400.SZ | 省广集团 | 11229.55 | | 603402.SH | 陕西旅游 | 9322.46 | | 301378.SZ | 通达海 | 9164.28 | | 301348.SZ | 蓝箭电子 | 8788.19 ...

新凤鸣所属申万行业为：基础化工-化学纤维-涤纶。所属概念板块包括：新材料、长三角一体化、增持 回购、融资融券、中盘等。 截至1月9日，新凤鸣股东户数1.82万，较上期增加0.17%；人均流通股83421股，较上期减少0.17%。 2025年1月-9月，新凤鸣实现营业收入515.42亿元，同比增长4.77%；归母净利润8.69亿元，同比增长 16.53%。 分红方面，新凤鸣A股上市后累计派现17.33亿元。近三年，累计派现7.20亿元。 机构持仓方面，截止2025年9月30日，新凤鸣十大流通股东中，香港中央结算有限公司位居第九大流通 股东，持股1673.14万股，为新进股东。 责任编辑：小浪快报 1月16日，新凤鸣盘中下跌2.01%，截至10:05，报20.52元/股，成交6142.74万元，换手率0.19%，总市值 312.84亿元。 资金流向方面，主力资金净流出371.73万元，特大单买入0.00元，占比0.00%，卖出104.15万元，占比 1.70%；大单买入1073.53万元，占比17.48%，卖出1341.10万元，占比21.83%。 新凤鸣今年以来股价涨5.45%，近5个交易日涨3.01%，近20 ...

Core Viewpoint - New City Holdings has experienced a decline in stock price and financial performance, with significant decreases in revenue and net profit year-over-year, indicating potential challenges in the real estate sector [1][2]. Group 1: Stock Performance - On January 16, New City Holdings' stock fell by 2.02%, trading at 14.52 yuan per share, with a total market capitalization of 32.752 billion yuan [1]. - The stock has increased by 4.09% year-to-date but has seen a decline of 3.26% over the last five trading days and 60 days [1]. - The net outflow of main funds was 4.2516 million yuan, with large orders accounting for 13.63% of purchases and 22.20% of sales [1]. Group 2: Financial Performance - For the period from January to September 2025, New City Holdings reported a revenue of 34.371 billion yuan, a year-over-year decrease of 33.34%, and a net profit attributable to shareholders of 0.974 billion yuan, down 33.05% [2]. - Cumulative cash dividends since the A-share listing amount to 14.595 billion yuan, with no dividends paid in the last three years [3]. Group 3: Shareholder Structure - As of September 30, 2025, the number of shareholders decreased by 12.34% to 43,200, with an average of 52,155 circulating shares per person, an increase of 14.07% [2]. - The fourth largest circulating shareholder is Hong Kong Central Clearing Limited, holding 16.6308 million shares, a decrease of 701,400 shares from the previous period [3]. - New shareholders include ICBC Value Selection Mixed A, holding 15.7412 million shares, while several other funds have exited the top ten circulating shareholders list [3].

Group 1 - The core viewpoint of the news is that Xiangyu Medical's stock has experienced fluctuations, with a recent decline of 2.02% and a year-to-date increase of 25.95% [1] - As of January 16, the stock price is reported at 76.20 yuan per share, with a total market capitalization of 12.192 billion yuan [1] - The company has seen a net outflow of main funds amounting to 20.5363 million yuan, with significant selling pressure from large orders [1] Group 2 - Xiangyu Medical, established on March 20, 2002, specializes in the research, production, and sales of rehabilitation medical devices, with a revenue composition of 67.79% from rehabilitation therapy equipment [2] - The company belongs to the pharmaceutical and biological industry, specifically in the medical device sector, and is involved in various concept sectors including brain-machine interface and robotics [2] - As of September 30, the company reported a revenue of 537 million yuan for the first nine months of 2025, reflecting a year-on-year growth of 6.00%, while the net profit attributable to shareholders decreased by 40.09% to 43.9815 million yuan [2] Group 3 - Since its A-share listing, Xiangyu Medical has distributed a total of 277 million yuan in dividends, with 157 million yuan distributed over the past three years [3] - As of September 30, 2025, the number of shareholders increased by 51.24% to 9,531, while the average circulating shares per person decreased by 33.88% to 16,787 shares [2][3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 918,600 shares, an increase of 12,530 shares compared to the previous period [3]

Group 1 - The stock price of Beifang Changlong has decreased by 2.01% to 143.63 CNY per share, with a trading volume of 1.27 billion CNY and a market capitalization of 13.674 billion CNY [1] - Year-to-date, Beifang Changlong's stock has increased by 1.89%, but it has dropped by 6.61% over the last five trading days [2] - The company specializes in the research, design, production, and sales of non-metal composite materials for military vehicle applications, with 70% of its revenue coming from human-machine interface systems for military vehicles [2] Group 2 - As of December 31, the number of shareholders for Beifang Changlong is 27,600, a decrease of 0.50% from the previous period [2] - For the period from January to September 2025, Beifang Changlong achieved a revenue of 122 million CNY, representing a year-on-year growth of 159.21%, and a net profit of 11.2885 million CNY, up by 208.52% [2] - The company has distributed a total of 43.384 million CNY in dividends since its A-share listing [3]